Back to UBS Group AG UBS Group AG

PCSAPCSA
3 quarters

Position history for UBS Group AGUBS Group AG's holdings in PROCESSA PHARMACEUTICALS INC

UBS Group AG holds 7,794 shares of PCSA (PROCESSA PHARMACEUTICALS INC), worth $14,964 as of 2026-Q2. The position was increased (+207.9% shares).

Current Value

$14,964

Current Shares

7,794

Total Value Change

-$21,439

Total Shares Change

-4,846

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
7,794
+207.9%
$14,9640.0%$1.92
20
2026-Q1
Decreased
2,531
-80.0%
$6,3910.0%$2.54
0
2025-Q4
New
12,640
-
$36,4030.0%$2.93
30

Other major holders of PCSA: JANE STREET GROUP, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, HRT FINANCIAL LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used